189 related articles for article (PubMed ID: 23482449)
21. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.
Morínigo R; Moizé V; Musri M; Lacy AM; Navarro S; Marín JL; Delgado S; Casamitjana R; Vidal J
J Clin Endocrinol Metab; 2006 May; 91(5):1735-40. PubMed ID: 16478824
[TBL] [Abstract][Full Text] [Related]
22. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
Chen CH; Stephens RL; Rogers RC
Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
[TBL] [Abstract][Full Text] [Related]
23. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340
[TBL] [Abstract][Full Text] [Related]
24. Autoradiographic reevaluation of the binding properties of 125I-[Leu31,Pro34]peptide YY and 125I-peptide YY3-36 to neuropeptide Y receptor subtypes in rat forebrain.
Gobbi M; Mennini T; Vezzani A
J Neurochem; 1999 Apr; 72(4):1663-70. PubMed ID: 10098875
[TBL] [Abstract][Full Text] [Related]
25. Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Gicquiaux H; Tschöpl M; Doods HN; Bucher B
Br J Pharmacol; 1996 Dec; 119(7):1313-8. PubMed ID: 8968537
[TBL] [Abstract][Full Text] [Related]
26. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
27. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
28. Effects of polypeptide YY(3-36) upon luteinizing hormone-releasing hormone and gonadotropin secretion in prepubertal rats: in vivo and in vitro studies.
Fernandez-Fernandez R; Aguilar E; Tena-Sempere M; Pinilla L
Endocrinology; 2005 Mar; 146(3):1403-10. PubMed ID: 15564330
[TBL] [Abstract][Full Text] [Related]
29. Attenuated peptide YY release in obese subjects is associated with reduced satiety.
le Roux CW; Batterham RL; Aylwin SJ; Patterson M; Borg CM; Wynne KJ; Kent A; Vincent RP; Gardiner J; Ghatei MA; Bloom SR
Endocrinology; 2006 Jan; 147(1):3-8. PubMed ID: 16166213
[TBL] [Abstract][Full Text] [Related]
30. Antisecretory mechanisms of peptide YY in rat distal colon.
Whang EE; Hines OJ; Reeve JR; Grandt D; Moser JA; Bilchik AJ; Zinner MJ; McFadden DW; Ashley SW
Dig Dis Sci; 1997 Jun; 42(6):1121-7. PubMed ID: 9201071
[TBL] [Abstract][Full Text] [Related]
31. Abdominal vagal mediation of the satiety effects of CCK in rats.
Reidelberger RD; Hernandez J; Fritzsch B; Hulce M
Am J Physiol Regul Integr Comp Physiol; 2004 Jun; 286(6):R1005-12. PubMed ID: 14701717
[TBL] [Abstract][Full Text] [Related]
32. Involvement of apolipoprotein A-IV and cholecystokinin1 receptors in exogenous peptide YY3 36-induced stimulation of intestinal feedback.
Whited KL; Tso P; Raybould HE
Endocrinology; 2007 Oct; 148(10):4695-703. PubMed ID: 17641001
[TBL] [Abstract][Full Text] [Related]
33. The role of peptide YY in integrative gut physiology and potential role in obesity.
Grudell AB; Camilleri M
Curr Opin Endocrinol Diabetes Obes; 2007 Feb; 14(1):52-7. PubMed ID: 17940420
[TBL] [Abstract][Full Text] [Related]
34. PYY regulates pancreatic exocrine secretion through multiple receptors in the awake rat.
Guarita DR; Deng X; Huh YB; Wood PG; Reeve JR; Whitcomb DC
Dig Dis Sci; 2000 Sep; 45(9):1696-702. PubMed ID: 11052307
[TBL] [Abstract][Full Text] [Related]
35. Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.
Dumont Y; Moyse E; Fournier A; Quirion R
J Mol Neurosci; 2007; 33(3):294-304. PubMed ID: 17952639
[TBL] [Abstract][Full Text] [Related]
36. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
37. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.
Reidelberger RD; Haver AC; Chelikani PK; Buescher JL
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R449-58. PubMed ID: 18550871
[TBL] [Abstract][Full Text] [Related]
38. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats.
Reidelberger RD; Haver AC; Apenteng BA; Anders KL; Steenson SM
Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304
[TBL] [Abstract][Full Text] [Related]
39. Identification and distribution of mRNA encoding the Y1, Y2, Y4, and Y5 receptors for peptides of the PP-fold family in the rat intestine and colon.
Goumain M; Voisin T; Lorinet AM; Laburthe M
Biochem Biophys Res Commun; 1998 Jun; 247(1):52-6. PubMed ID: 9636652
[TBL] [Abstract][Full Text] [Related]
40. Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY.
Unniappan S; McIntosh CH; Demuth HU; Heiser U; Wolf R; Kieffer TJ
Diabetologia; 2006 Aug; 49(8):1915-23. PubMed ID: 16802131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
